Skip to content
The Future Explorerby Benjamin Talin
Enablertechnologicalemerging

Senolytics Therapy

Drugs designed to clear out 'senescent' cells: old cells that have stopped dividing but refuse to die, and leak inflammatory signals that may drive ageing. The drugs block the survival tricks those cells rely on, so the body removes them. In mice, clearing these cells extends healthy life, a result that has been repeated. Human trials are early and mixed, while the public's appetite for an anti-ageing pill is almost unlimited.

Readiness

TRL4
SRL6
Gap-2

hype riskHype risk: expectations are running ahead of what the technology can deliver.

Not scored. Watchlist entries do not enter any gradient. WKO Innovation Map 26/27 (2026)

Drugs that selectively kill senescent cells - cells that have stopped dividing but persist, secreting inflammatory signals, accumulating with age.

The biology is one of the better-supported mechanisms in ageing research. Clearing senescent cells in mice extends healthy lifespan and improves function across several tissues, and that result has replicated. The candidate compounds are largely repurposed drugs, which shortens the path.

Technical readiness 4 against societal readiness 6, and that two-point gap is the entry's point. The appetite for a treatment that slows ageing is close to unlimited, human trials are early and have produced mixed results, and the space between those two facts is already full of supplements sold on the strength of the mouse data. Chapter 14's mechanism is operating here in a consumer market rather than a policy one.

Common misconception: that the mouse results transfer. Interventions that extend mouse lifespan have a long history of not extending human lifespan, and this one is at the beginning of finding out.

Possibly related megatrends - unreviewed

Unreviewed. Derived from this technology's WKO cluster, not from a judgement about this technology. A starting point for review, not a claim.

Talin, B. (2026). Senolytics Therapy. The Future Explorer, dataset v0.4.0 (2026-11-16). https://explorer.talin.digital/e/senolytics-therapy/